COVID-19 studies

covid vaccine 457x220

Nationally prioritised and/or expedited studies open at Southampton

See NIHR'S list of all national priority studies here.


Full title: Randomised evaluation of COVID-19 therapy

Comparison of existing HIV treatment (Lopinavir-Ritonavir) and antiinflammatory steroid (dexamethasone) in treating COVID-19.

Local PI: Dr Sophie Fletcher (
Contact: or 023 8120 8141

Trial website: 

Find out more


Full title: A Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia

A multi-centre international adaptive platform trial of critically ill patients with community acquired pneumonia, including COVID-19. It has multiple domains to evaluate multiple interventions simultaneously, including antivirals and immunomodulators, and will also evaluate potential interactions.

Local PI: Dr Ahilanadan Dushianthan (

Trial website:

Find out more

COVID-19 vaccine trial 

Full title: A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19

This study will enable us to assess how well people of all ages can be protected from COVID-19 with this new vaccine called ChAdOx1 nCoV-19. It will also give us valuable information on safety aspects of the vaccine and its ability to generate good immune responses against the virus.

Local PI: Prof Saul Faust (

Find out more: 


Full title: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID 19 in Hospitalised Patients

There are currently no approved therapeutic agents available to treat coronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), the causative agent of COVID 19 disease, and there is an urgent public health need for rapid development of such interventions.

This adaptive platform study is designed to rapidly assess multiple candidate agents as treatments for COVID 19. 

Six potential drugs will initially enter the programme, with the first three of these beginning Phase 2 studies, which assess how well they work and their safety. Those showing promise will be fed into UK's large-scale COVID-19 studies such as the RECOVERY trial.

Local PI: Dr Mark Jones ( (CI: Prof Tom Wilkinson)

Find out more:


Full title: Clinical Characterisation Protocol for Severe Emerging Infection

This study is designed for the rapid, coordinated clinical investigation of patients with confirmed novel coronavirus infection. The study has been designed to maximize the likelihood that as much data as possible is collected and shared rapidly in a format that can be easily aggregated, tabulated and analysed across many different settings globally. The study is designed to have some level of flexibility in order to ensure the broadest acceptance.

Local PI: Dr Ahilanadan Dushianthan (


Online questionnaire monitoring coronavirus infection children and adults vulnerable to infection.

Local PI: Dr Hans de Graaf (

Find out more

SARS-CoV-2 infection

A randomised double-blind placebo-controlled trial to determine the safety and efficacy of inhaled SNG001 (IFN-β1a for nebulisation) for the treatment of patients with confirmed SARS-CoV-2 infection.

Local PI: Prof Tom Wilkinson (

What's the STORY

Prevalence of viral antibodies in the child-age population (0 – 24 years) through analysis of routine blood samples, expanding to include COVID-19.

Local PI: Prof Saul Faust (

Study website:


Full title: Genetics of susceptibility and mortality in critical care

Susceptibility to COVID-19 is almost certainly, in part, genetic. GenOMICC can find the genes that cause susceptibility, which may help us to prioritise treatments to respond to the global crisis. GenOMICC was designed for this crisis. Since 2016, the open, global GenOMICC collaboration has been recruiting patients with emerging infections, including COVID-19. All patients with confirmed COVID-19 in critical care are eligible for GenOMICC.

Local PI: Dr Rebecca Cusack (

UKOSS: Pandemic Influenza in Pregnancy

Full title: Maternal and Perinatal Outcomes of Pandemic Influenza in Pregnancy

The study will use the UK Obstetric Surveillance System (UKOSS) to collect information about all pregnant women admitted to hospital who are confirmed to have the virus infection. Specifically, the study will describe incidence, management and outcomes of COVID-19 in pregnancy and identify factors associated with better outcomes for women and their babies.

Local PI: Dr Nazia Irsnad


Full title: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis

The overall aim of DIAMONDS is to design new diagnostic tests that can tell quickly and accurately what illness a patient has when they come to hospital with common symptoms such as fever. It is recruiting children and adults of all ages with suspected and proven COVID-19.  

Local PI: Prof Saul Faust (

Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection

The primary objective of this study is to provide expanded access of RDV for the treatment of SARS-CoV2 infection.

Local PI: Dr Ahilanadan Dushianthan (

RECOVERY-Supportive Care

Full title: Ventilation Strategies in COVID-19; CPAP, High-flow, and standard care

This trial will look at three different approaches to providing ventilatory support to patients suspected or confirmed COVID-19, all of which are currently in use in clinical practice at present;

  • High Flow Nasal Oxygen (HFNO)
  • Continuous Positive Airway Pressure (CPAP)
  • standard care involving regular oxygen therapy

We will see which is more effective in relation to survival of patients and intubation.

Local PI: Dr David Land (

COVIPOC (closed)

Biofire rapid diagnostics in COVID-19.

Local PI: Dr Tristan Clark (

Other COVID-19 studies at Southampton

The COVID-19 resilience project

Online survey researching the impact of COVID-19 on the NHS workforce to guide psychological support for staff.

You can participate if you are an NHS clinical member of staff, whose job role involves direct patient contact and care provision. 

Take part:

Find out more:

Psychological impact of COVID- 19

An online questionnaire exploring the psychological impact of the coronavirus, its effect on our emotions, behaviour and wellbeing.

The aim of this survey is to better understand how the coronavirus and the impact the current lockdown is having on our day to day lifestyle. We hope to find out what is helpful for people during this time and also what may be causing some people to be affected more than others in terms of their wellbeing.

Anyone over the age of 16 with access to be able to complete this online questionnaire, which takes takes around 15 minutes to fill in, can take part.

Take part:

Understanding impacts of COVID-19 restrictions on young people

A study engaging young people in Southampton and surounding areas about their experiences and concerns under lock down measures, to identify and develop solutions that support their wellbeing, mental and physical health.

Local PI: Prof Mary Barker (

Examining T cell responses in virus infection (ExCel)

A study looking at blood and tissue samples from patients who are known to have a viral infection to help us better understand how the immune system works. The purpose of this project is to improve our knowledge of how the immune system works in lung diseases.

Local PI: Dr Serena Chee

Public Health England Seroepidemiology Programme 2020 + COVID-19 Response

Ongoing study measuring prevalence of viral antibodies in the population through analysis of routine blood samples, expanding to include COVID-19.


Full title: How to support children with cancer and their parents during the COVID-19 outbreak?: understanding experiences, information and support needs, and decision-making

This study aims to:

  • explore experiences, information and support needs and decision-making
  • explore how these change over time as the situation with COVID-19 evolves
  • evaluate whether online intervention iHOPE to support families helps reduce anxiety and stress

To take part in the SHARE study survey, parents should visit and children and young people should visit

Local PI: Dr Juliet Gray ( Prof Sophie-Anne Darlington)

Investigating and forecasting the impact of COVID-19 in Emergency Departments

To evaluate the impact of Covid-19 on the operations of Emergency Departments. Answering questions such as: at what times of day are the ED busiest with COVID-19 cases.

Local PI: Dr Michael Kiuber (

COVID-19 Emergency Response Assessment (CERA)

The CERA study will aim to understand the evolving and cumulative effects of working during the COVID-19 outbreak on the psychological health of those physicians working in the Emergency Department during the pandemic wave of the 2020 UK outbreak.

Local PI: Dr Peter Ellis (

Germ Defence

Full title: Rapid co-design, implementation and evaluation of a digital behaviour change intervention to improve hand hygiene and limit spread of the COVID-19 outbreak

Project to evaluate how the existing digital public health intervention Germ Defence can be very rapidly adapted and optimised for the changing needs of an infection outbreak, using novel participatory-co-design methods.

Local PI: Prof Lucy Yardley (


Full title: COVID-19 infections in people with Primary Ciliary Dyskinesia

International longitudinal survey of COVID-19 infections in people with Primary Ciliary Dyskinesia.

Local PI: Prof Jane Lucas (


Full title: A clinical trial of bovactant (Alveofact ®) for the Treatment of moderate to severe COVID-19

To assess improvement in oxygenation and pulmonary ventilation in patients with COVID-19 after treatment with the surfactant Alveofact ®.

Local PI: Dr Ahilanadan Dushianthan (

UK Coronavirus Cancer Monitoring Project

The aims of this project are to ensure adequate cancer care is being delivered where required across the country and to assess the impact on cancer patients.

Local PI: Prof Ellen Copson (


Full title: Virtual clinics to deliver universal interventions to maintain and improve mental and physical health in people with cancer who are following solcial distancing guidance: a COVID-19 targeted trial

Aims to investigate whether the promotion of these interventions delivered via virtual clinics in socially distanced people with cancer can improve physical and psychological function and self-efficacy to self-manage. We are also aiming to evaluate health economics.

Local PI: Prof Sandy Jack (

The GOOD-Night COVID study

Full title: GOOD nasal irrigation and gargling to halt transmission of COVID-19 to care-home-based vulnerable Individuals

A cluster randomised trial of saline rinse and mouth gargle at the onset of viral upper respiratory tract symptoms in healthy participants in care home residents and care home carers.

Local PI: Dr Thomas Daniels (

Pregnancy and Neonatal Outcomes in COVID-19

Aims to better understand some specific research questions as to how COVID-19 affects early pregnancy, fetal growth, prematurity and virus transmission to the baby.

Local PI: Dr Alex Kermack (

Characterisation of a novel ACE-2 transcript in nasal epithelium

Characterisation of a novel ACE-2 transcript in nasal epithelium.

Local PI: Prof Jane Lucas (


Full title: Women's Responses to Adjustment in Product Placement and its Effects on Diet

Interviews with participants to find out about their shopping experiences during the pandemic.

Local PI: Prof Janis Baird (